LifeStance 10-Q: Q3 Revenue Up 25% to $455.9M, Net Income $22.4M; Material Weaknesses Persist
LFST has more than doubled off its 52-week low of $4.79 on elevated volume (2.5× avg).
Summary
LifeStance's Q3 10-Q shows revenue up 25% to $455.9 million and net income of $22.4 million, with $170.0 million of nine-month operating cash flow funding $122.4 million of buybacks — while previously reported material weaknesses in internal controls remain unremediated.
Key Events · Earnings and Guidance · LFST
-
Q3 Revenue Jumps 25% to $455.9M
Total revenue rose to $455.9 million from $363.8 million, driven by 867 more clinicians and 0.4 million more patient visits (up 17%).
-
Net Income $22.4M, EPS $0.06
Operating income was $33.1 million versus $7.4 million a year ago; nine-month net income reached $60.2 million versus a $2.0 million loss.
-
Operating Cash Flow Nearly Doubles
Nine-month operating cash flow was $170.0 million versus $88.6 million, with cash and equivalents of $218.8 million at September 30, 2026.
-
$122.4M of Buybacks Completed
The company repurchased 15,000,000 shares for $122.4 million in the nine months, leaving $75.4 million under the $100 million program approved August 5, 2026.
Analysis · LFST · Industrial Applications And Services
The 10-Q confirms the quarter the 8-K previewed this morning: revenue of $455.9 million (up 25%), operating income of $33.1 million versus $7.4 million, and net income of $22.4 million, or $0.06 diluted EPS. Cash generation is the standout — $170.0 million from operations in nine months versus $88.6 million a year earlier — and the company spent $122.4 million repurchasing 15.0 million shares, leaving $75.4 million on the $100 million authorization. Against that, management again states that material weaknesses in internal control over financial reporting continue to exist as of September 30, 2026 and that disclosure controls were not effective; remediation is underway but not complete. That unresolved control issue is the main thing standing between these results and a cleaner story.
How filings like this one have moved
In the 30 days to Nov 6, 2026, 44.9% of the 1410 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LFST was trading at $13.43 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.1B. The 52-week trading range was $4.79 to $15.66. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.